ACXP - Acurx Pharmaceuticals GAAP EPS of -$1.49 beats by $0.20 March, 17 2022 07:30 AM Acurx Pharmaceuticals Inc. Acurx Pharmaceuticals press release (NASDAQ:ACXP): FY GAAP EPS of -$1.49 beats by $0.20. Cash balance of $12.96M as of December 31, 2021 For further details see: Acurx Pharmaceuticals GAAP EPS of -$1.49 beats by $0.20